Adil Doganay Duru

Company: Glycostem Therapeutics

Job title: Director, Business Development

Seminars:

Deploying Assays to Demonstrate Effective Cell Depletion & Immunosuppression 9:00 am

Assays are critical for demonstrating early efficacy prior to clinical entry. With uncertainty of requirements across cell therapies and how best to measure cell depletion and immune suppression, this workshop will explore the use of cytokine release profiles and targeted biomarker assays, offering insights into selecting the right approach and outlining requirements for approval. Discuss…Read more

day: Pre-Conference Workshop Day Pink Track P1